Diamyd Medical receives patent protection in the US and Japan for GABA formulation Remygen® – Marketscreener.com
Diamyd Medical receives patent protection in the US and Japan for GABA formulation Remygen® Marketscreener.com
In: PATENT NEWS
Diamyd Medical receives patent protection in the US and Japan for GABA formulation Remygen® Marketscreener.com
In: PATENT NEWS
HeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart Disease Yahoo Finance
In: PATENT NEWS
NPE Showcase: NPE Litigation In 2023 – What To Expect – Patent … mondaq.com
In: PATENT NEWS
Kadimastem Awarded Patent in Australia for its AstroRx® Technology for the Treatment of ALS and Drug Scre Benzinga
In: PATENT NEWS
Cyxone advances the patent portfolio for Rabeximod Marketscreener.com
In: PATENT NEWS
Molecular Switches Intellectual Property Landscape Report 2022: Synthetic Molecules, Such as Rotaxanes and Catenanes have Emerged as Potential Molecular Switches Yahoo Finance
In: PATENT NEWS
Final Weeks to Register for the 2 Day Virtual Course: Formal … GlobeNewswire
In: PATENT NEWS
Commissioned authentication before patent litigation – China | Law … Law.asia
In: PATENT NEWS
Director Vacates PTAB Adverse Judgments In Precedential Director … mondaq.com
In: PATENT NEWS
Nike Air Penny 2 Arrives in Classic “Black Patent” HYPEBEAST
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION